Research we are funding

The Muscular Dystrophy Campaign funds world-class pioneering research into potential treatments and cures for people with muscular dystrophy and related neuromuscular conditions, from basic science and translational research to clinical pilot studies. To see information about individual types of grants, click on the links below.

• Clinical Training and Research Fellowships
• PhD studentships
• Project grants
• Clinical trial coordinators
• Show all
  

Therapeutic approaches:

 20 September 2012
Searching for treatments for myotonic dystrophy Dr Saam Sedehizadeh at the University of Nottingham will test chemicals for the potential to treat myotonic dystrophy.
  1 March 2012
Improving the delivery of molecular patches to the muscle In this project Professor Wells and his PhD student will investigate ways to improve the delivery of molecular patches so they can reach all the muscles more easily.
  1 February 2012
Using exon skipping to boost muscle growth Prof George Dickson plans to build on the current exon skipping work to develop molecular patches that can block the activity of a protein called myostatin and boost muscle growth.
 17 October 2011
Developing an animal model to test therapies for certain types of muscular dystrophy Dr Susan Brown, Royal Veterinary College will supervise a student to study two conditions caused by changes in a gene called FKRP
 10 October 2011
Moving closer to an effective treatment for spinal muscular atrophy This project will test whether a very important, but often overlooked, type of cell that supports motor neurons contribute to the onset and severity of spinal muscular atrophy.
  1 August 2011
Developing a utrophin drug for Duchenne and Becker muscular dystrophies Professor Dame Kay Davies and colleagues are searching for drugs that could increase the amount of a protein called utrophin, in the muscles.
 25 October 2010
How does ephedrine improve the symptoms of congenital myasthenia and could it be used for myasthenia gravis? Prof Beeson and his colleagues aim to study the drug ephedrine to find out why it is effective for people with a type of congenital myasthenic syndrome (CMS) and if ephedrine could be useful for some people with myasthenia gravis.
  1 October 2010
Improving exon-skipping for Duchenne muscular dystrophy Dr Wood and PhD student Corinne Betts at the University of Oxford aim to investigate ways to improve upon the current exon-skipping technology.
 17 November 2009
Investigating potential treatments for the myasthenias Prof Beeson will supervise this three year PhD studentship in Oxford with the overall aim of investigating treatment and diagnostic approaches for the myasthenias.